IDEAYA Biosciences, Inc.
- IDYA
- NASDAQ
- Biotechnology
- Precision Oncology
- Synthetic Lethality
- Targeted Cancer Therapies
$33.43
Today +1.77%Quote Oct 19, 2026, 02:35 PM UTC
−14.92%over the last month
Max drawdown −17.3%From 1-month high −17.3%3 months −7.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$3.23B
Quote Oct 19
Next earnings
Nov 9
Expected, not confirmed
Analyst target
$57.00
+70.5% from here
Floor
$33.12
0.9% below price
Where the price sits
26 analysts
Analyst range, low to high
$48.00$63.00
- Price $33.43
- Resistance $34.56–$34.90
- Consensus $57.00
The price is just above its floor. Analysts' average target sits about 71% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about IDYAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
145